{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:46:27Z","timestamp":1766760387093,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.aace.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T04:26:51Z","timestamp":1634876811000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Camurati-Engelmann Disease Complicated by Hypopituitarism: Management Challenges and Literature Review of Outcomes With Bisphosphonates"],"prefix":"10.1016","volume":"8","author":[{"given":"Liza","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinaki","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Steenackers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretl","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devi","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aace.2021.10.002_bib1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00223-019-00532-1","article-title":"Camurati\u2013Engelmann disease","volume":"104","author":"Van Hul","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.aace.2021.10.002_bib2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archoto.2010.68","article-title":"Skull base manifestations of Camurati-Engelmann disease","volume":"136","author":"Carlson","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.aace.2021.10.002_bib3","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1210\/jc.2014-2025","article-title":"Elimination of pain and improvement of exercise capacity in Camurati-Engelmann disease with losartan","volume":"99","author":"Ayyavoo","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.aace.2021.10.002_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000479859","article-title":"Significant improvement of clinical symptoms, bone lesions, and bone turnover after long-term zoledronic acid treatment in patients with a severe form of Camurati-Engelmann disease","volume":"8","author":"Baroncelli","year":"2017","journal-title":"Mol Syndromol"},{"issue":"2","key":"10.1016\/j.aace.2021.10.002_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00223-013-9804-9","article-title":"Camurati\u2013Engelmann disease (progressive diaphyseal dysplasia): reports of an Indian kindred","volume":"94","author":"Bhadada","year":"2014","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"10.1016\/j.aace.2021.10.002_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10067-004-1056-7","article-title":"Camurati-Engelmann disease: failure of response to bisphosphonates: report of two cases","volume":"24","author":"Castro","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.aace.2021.10.002_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/09513590.2012.760196","article-title":"Hypothalamic amenorrhea in a Camurati-Engelmann disease\u2013a case report","volume":"29","author":"Meczekalski","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.aace.2021.10.002_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4158\/EP.11.6.399","article-title":"Camurati-Engelmann disease in conjunction with hypogonadism","volume":"11","author":"Gupta","year":"2005","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.aace.2021.10.002_bib9","article-title":"Camurati-Engelmann disease association with hypogonadism and primary hypothyroidism","volume":"16","author":"Low","year":"2014","journal-title":"Iran Red Crescent Med J"},{"issue":"6","key":"10.1016\/j.aace.2021.10.002_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/er.2004-0001","article-title":"Transforming growth factor-\u03b21 to the bone","volume":"26","author":"Janssens","year":"2005","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.aace.2021.10.002_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s002239900293","article-title":"Biochemical markers of bone turnover in Camurati\u2013Engelmann disease: a report on four cases in one family","volume":"61","author":"Hern\u00e1ndez","year":"1997","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"10.1016\/j.aace.2021.10.002_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.13941","article-title":"Bone-targeted delivery of TGF-\u03b2 type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati\u2013Engelmann disease","volume":"1433","author":"Qin","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.aace.2021.10.002_bib13","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1007\/s00198-016-3604-9","article-title":"Multiple diaphyseal sclerosis (Ribbing disease): what about neridronate?","volume":"27","author":"Di Carlo","year":"2016","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.aace.2021.10.002_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jbspin.2013.01.007","article-title":"Treatment responses in five patients with Ribbing disease including two with 466C> T missense mutations in TGF\u03b21","volume":"80","author":"Savoie","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.aace.2021.10.002_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00774-007-0783-7","article-title":"A\u00a0significant improvement in lower limb pain after treatment with alendronate in two cases of Camurati\u2013Engelmann disease","volume":"26","author":"Iba","year":"2008","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"8","key":"10.1016\/j.aace.2021.10.002_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/00003072-200108000-00003","article-title":"Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease)","volume":"26","author":"Inaoka","year":"2001","journal-title":"Clin Nucl Med"},{"issue":"suppl 1","key":"10.1016\/j.aace.2021.10.002_bib17","first-page":"56","article-title":"Clinical, humoral and scintigraphic assessment of a bisphosphonate as potential treatment of diaphyseal dysplasia: ribbing and Cammurati-Engelmann diseases. Article in Spanish","volume":"57","author":"De Rubin","year":"1997","journal-title":"Medicina"},{"issue":"10","key":"10.1016\/j.aace.2021.10.002_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10067-006-0511-z","article-title":"Bone biopsy and densitometry findings in a child with Camurati\u2013Engelmann disease","volume":"26","author":"Bondestam","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.aace.2021.10.002_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/24725625.2019.1629571","article-title":"Efficacy of denosumab therapy after alendronate treatment for a 66-year-old woman with Camurati\u2013Engelmann disease and osteoporosis: a case report","volume":"4","author":"Uehara","year":"2020","journal-title":"Mod Rheumatol Case Rep"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060521001073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060521001073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:32:25Z","timestamp":1762497145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060521001073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2376060521001073"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2021.10.002","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Camurati-Engelmann Disease Complicated by Hypopituitarism: Management Challenges and Literature Review of Outcomes With Bisphosphonates","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}